A detailed history of Bio Impact Capital LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 5,641,894 shares of CMPX stock, worth $9.53 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
5,641,894
Previous 5,005,086 12.72%
Holding current value
$9.53 Million
Previous $5.01 Million 107.41%
% of portfolio
1.62%
Previous 0.8%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.8 - $1.88 $509,446 - $1.2 Million
636,808 Added 12.72%
5,641,894 $10.4 Million
Q2 2024

Aug 14, 2024

BUY
$1.0 - $1.85 $3.03 Million - $5.61 Million
3,033,684 Added 153.88%
5,005,086 $5.01 Million
Q1 2024

May 15, 2024

BUY
$1.2 - $2.29 $2.37 Million - $4.51 Million
1,971,402 New
1,971,402 $3.9 Million

Others Institutions Holding CMPX

About Compass Therapeutics, Inc.


  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $171M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.